维普中文期刊产品整合服务
25篇 您的检索式:作者名="Sweeney WE"
    题名 作者 年代 出处 被引量
1Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease显示文摘 Sweeney WE Yoder BK 1998J Clin Invest1998,101,5:1
2Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor显示文摘 Chen Y Nakanishi K 2000Kidney Int2000,57,1:1
3Significant re- duction in inflammatory response in the h~acaque model of chlamydial pelvic inflammatory disease with azithromycin treat- ment 显示文摘Patton DL Cosgrove Sweeney YT Stamm WE 2005The Journal of Infectious Diseases2005,192,1:1
4Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease显示文摘Richarda WG Sweeney WE Yoder BK 1998J Clin Invest1998,101,3:1
5Epidermal growth{actor receptor tyrosine kinase inhibition is not protective in PCK rat显示文摘Tortes VE Sweeney WE Jr Wang X 2004Kidney Int2004,66,:1
6New insights into the molecular pathophysiology of polycystic kidney disease显示文摘Murcia NS Sweeney WE Jr Avner ED 1999Kidney Int1999,55,4:1
7Sirtuin 1 inhibition delays cyst formation in autosomal- dominant polycystic kidney disease显示文摘Zhou X Fan LX Sweeney WE 2013J Clin Invest2013,123,7:1
8Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment 显示文摘Patton DL Sweeney YT Stamm WE 2005J Infect Dis2005,192,:1
9Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease显示文摘Richards WG Sweeney WE Yoder BK 1998J Clin Invest1998,101,7:1
10A novel inhibitor of tumor necrosis factor-α converting enzyme ameliorate polycystic kidney disease显示文摘Dell KM Nemo R Sweeney WE 2001Kidney Int2001,60,7:1
11Src inhi- bition ameliorates polycystic kidney disease显示文摘Sweeney WE Jr yon Vigier RO Frost P 2008J Am Soc Nephrol2008,19,7:1
12Combina- tion treatment of PKD utilizing dual inhibition of EGF- receptor activity and ligand bioavailability显示文摘Sweeney WE Jr Hamahira K Sweeney J 2003Kidney Int2003,64,4:1
13New insights into the molecular pathophysiology of polycystic kidney disease显示文摘 Sweeney WE Jr Avner ED 1999Kidney Int1999,55,:1
14A new colorimetric method for pyrethrins显示文摘Williams WE Dale WE Sweeney JP 1956J Ass Office Anal Chem1956,39,3:1
15Efficacy of taxol in the orpk mouse model of polycystic kidney disease 显示文摘Sommerdahl CS Woychik RP Sweeney WE 1997Pediatric Nephrology1997,11,:1
16Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability显示文摘Sweeney WE Jr Hamahira K Sweeney J 2003Kidney Int2003,64,10:1
17Functional activity of epidermal growth factors in autosomal recessive polycystic kidney disease显示文摘Sweeney WE Avner ED 1998Am J Physiol1998,275,32:1
18EGF-related growth factors in the pathogenesis of murine ARPKD 显示文摘Dell KM Nemo R Sweeney WE Jr 2004Kidney Int2004,65,6:1
19Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease显示文摘Richards WG Sweeney WE Yoder BK 1998J Clin Invest1998,1017,:1
20Value of pancreatic resection for cancer metastatic to the pancreas 显示文摘Sweeney AD Fisher WE Wu MF 2010J Surg Res2010,160,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费